PHARMATRAIN News Contact

Eu2P

Eu2P Master Degree in Pharmacovigilance and Pharmacoepidemiology

Practical Information

Commencing Date :
Anytime
Language :
English
Location :
World Wide (Distance Learning)


Teaching Methodology :
Distance Learning


European Fees :
14 000 EUR
Non European Fees :
14 000 EUR
Scholarship Possibilities :
No

Course Contact

Eu2P Office

+ (33) 5 57 57 92 57

contact@eu2p.org


Website

Office Link

Eu2P

University Accreditation : Yes

PharmaTrain Centre

Description

The Eu2P Master is an academic post-graduate diploma in pharmacovigilance and pharmacoepidemiology jointly delivered by the seven European academic bodies working together as Eu2P partners. The Eu2P European Master is built and recognised by all the 24 academic, regulatory and industrial Eu2P partners. Eu2P courses are grounded in real job market and today's practices and research projects can be performed in public or private environments. Eu2P programme is being noticed and recognised world-wide* as an excellent opportunity to get jobs and improve regulatory sciences. In second year, choose a Master specialization among Benefit assessment of medicines, Medicines risk identification and quantification, Medicines benefit-risk assessment, Medicines and public health, Medicines risk communication domains or select "à la carte" modules to match specific needs. Awarded for e-learning quality, Eu2P online courses can be attended at home and work. See Eu2P Training Excellence : http://www.eu2p.org/study-with-eu2p/training-excellence Master year 1 or 2 curriculum can be performed on a full or part time basis to suit your time availiability. Scholarships and fees discouts can be offered under eligibility conditions.

IMI Standards

  • A predefined set of teaching objectives, leading to defined learning outcomes
  • Assessment of the students' achievement in accordance with the agreed learning outcomes of the training offered
  • A system for collecting, assessing and addressing feedback from learners, teachers, technical / administrative staff and programme / course / module managers
  • Availability of appropriate and regularly reviewed reference material (e.g. published articles, links, book chapters, scripts, etc)
  • Defined and transparent admission criteria
  • Quality assurance of teaching staff
  • Regular review of the QA/QC process and demonstration that the training is further developed in light of this review
  • The facilities, infrastructure, leadership and competences available for the support of student learning
  • University accreditation OR a system for approving, monitoring and reviewing the training offered


Modules

Module Title

Type

Duration

Credits

CPD

Basics in Epidemiology Applied to Pharmacovigilance and Pharmacoepidemiology Core Part Time 3.0 ECTS
Basics in Statistics Applied to Pharmacovigilance and Pharmacoepidemiology Core Part Time 3.0 ECTS
Valorisation and Critical Appraisal in Research Core Part Time 6.0 ECTS
Basics in Clinical Pharmacology Core 3.0 ECTS
Basics in Medicine Risk Communication Core Part Time 3.0 ECTS
Practical Training Core Full Time 3.0 ECTS No
Information and Communication About Benefit-Risk of Medicines (Basic Principles) Core Part Time 3.0 ECTS
Key Roles and Stakeholders in Medicines Risk Communication: Duties and Challenges Elective 3.0 ECTS
Case studies in Medicines Risk Communication Elective Part Time 3.0 ECTS
Drug Utilisation Studies: Introduction and Quantitative Methods Core Part Time 3.0 ECTS
Drug Utilisation Studies: Qualitative Methods Elective Part Time 3.0 ECTS
The Public Health Impact of Adverse Drug Reactions Elective Part Time 3.0 ECTS
Advanced Quantitative Benefit-Risk Assessment Methods in Decision Making On Medicines Elective Full Time 3.0 ECTS
Fundamentals of Quantitative Benefit-Risk Assessment Methods in Decision Making On Medicines Elective Part Time 3.0 ECTS
Principles of Pharmacoeconomics and Valuation of Health States Elective Part Time 3.0 ECTS
Identifying Susceptibility for Adverse Drug Reactions Elective Part Time 3.0 ECTS
Substantiation and Quantification of Risks Elective Part Time 6.0 ECTS
Principles of Identifying and Recognizing Adverse Events and Safety Signals Core Part Time 3.0 ECTS
Pharmacovigilance Regulations Core Part Time 3.0 ECTS
Pharmacovigilance Regulatory Processes Elective Part Time 3.0 ECTS
Clinical and Pharmacological Principle Core Part Time 3.0 ECTS
Methods in Clinical Research, Pharmacoepidemiology and in the Assessment of the Efficacy of Medicines Elective Part Time 3.0 ECTS
Critical Appraisal of Clinical Trials: Evidence-Based Medicine and Its Uncertainties Elective Part Time 3.0 ECTS
Introduction to Benefit-Risk Assessment and Pharmacoeconomics Communication in Decision Making Core Part Time 3.0 ECTS